07.27.15
Monrovia, Calif.-based Staar Surgical Company has appointed Jon K. Hayashida, O.D., to the position of vice president of global clinical and medical affairs. In this position he will head the company's strategic initiative in building clinical validation and clinical utility for Staar's continuum of lenses for the myopic, presbyopic and cataract vision care markets.
"We are thrilled to welcome Jon to our team," said Caren Mason, president and CEO of Staar Surgical. "He has demonstrated excellence throughout his career in building and leading global teams with a track record of conducting successful ophthalmic clinical trials in Europe, Asia and North America leading to [U.S. Food and Drug Administration (FDA) premarket approvals (PMAs)] and CE mark approvals in implantable lenses and delivery systems for the eye. In addition, Jon has maintained his clinical care specialty certifications and will provide excellent medical affairs assistance to refractive and cataract surgeons and their teams working with our resident M.D.s, O.D.s and Field Medical Monitor Dr. John Vukich."
Hayashida's professional career includes experience in corporate eye care, ophthalmic start-up companies and direct patient care. He held the position of vice president of clinical and medical affairs for Bausch and Lomb, Surgical, where he gained FDA approvals for both the Glistening-free Envista Hydrophobic Acrylic IOL (intraocular lense) and PMA approval for the Trulign Toric Accommodating IOL. He also held clinical affairs leadership and research positions with Cooper Vision and Allergan. His ophthalmic start-up company experience includes vice president clinical affairs for Wavetec Vision, Transcent Medical and Refractec where he directed, planned and executed successful FDA PMA approvals. Hayashida has served as a clinical care specialist at the University of California – Los Angeles (UCLA) Laser Refractive Center, Jules Stein Institute, UCLA School of Medicine. He has served most recently as vice president of programs and services for the Braille Institute of America. Hayashida is a fellow of the American Academy of Optometry and a diplomate in its Cornea and Contact Lens and Refractive Technologies section.
Staar Surgical makes implantable lenses, and accompanying delivery systems, for the eye.
"We are thrilled to welcome Jon to our team," said Caren Mason, president and CEO of Staar Surgical. "He has demonstrated excellence throughout his career in building and leading global teams with a track record of conducting successful ophthalmic clinical trials in Europe, Asia and North America leading to [U.S. Food and Drug Administration (FDA) premarket approvals (PMAs)] and CE mark approvals in implantable lenses and delivery systems for the eye. In addition, Jon has maintained his clinical care specialty certifications and will provide excellent medical affairs assistance to refractive and cataract surgeons and their teams working with our resident M.D.s, O.D.s and Field Medical Monitor Dr. John Vukich."
Hayashida's professional career includes experience in corporate eye care, ophthalmic start-up companies and direct patient care. He held the position of vice president of clinical and medical affairs for Bausch and Lomb, Surgical, where he gained FDA approvals for both the Glistening-free Envista Hydrophobic Acrylic IOL (intraocular lense) and PMA approval for the Trulign Toric Accommodating IOL. He also held clinical affairs leadership and research positions with Cooper Vision and Allergan. His ophthalmic start-up company experience includes vice president clinical affairs for Wavetec Vision, Transcent Medical and Refractec where he directed, planned and executed successful FDA PMA approvals. Hayashida has served as a clinical care specialist at the University of California – Los Angeles (UCLA) Laser Refractive Center, Jules Stein Institute, UCLA School of Medicine. He has served most recently as vice president of programs and services for the Braille Institute of America. Hayashida is a fellow of the American Academy of Optometry and a diplomate in its Cornea and Contact Lens and Refractive Technologies section.
Staar Surgical makes implantable lenses, and accompanying delivery systems, for the eye.